AI Policy

Artificial Intelligence (AI) Usage Policy

Indonesian Journal of Pharmaceutical Research (Jurnal Riset Kefarmasian Indonesia, JRKI)

The Indonesian Journal of Pharmaceutical Research (Jurnal Riset Kefarmasian Indonesia, JRKI) has established a policy governing the use of Artificial Intelligence (AI) technologies throughout all stages of scholarly publication to safeguard academic integrity, the originality of scientific work, accountability, and the credibility of the publication process. This policy applies to all parties involved in the publication process, including Authors, Editors, Reviewers (Peer Reviewers), Copy Editors, and Production Editors.

1. Policy for Authors

  1. Authors are strictly prohibited from using generative AI technologies to generate, develop, or write any part or the entirety of a manuscript submitted to the Indonesian Journal of Pharmaceutical Research.

  2. Authors are prohibited from listing AI tools, chatbots, or generative AI systems as authors or co-authors of a manuscript, whether on the title page, in the author contribution statement, or in any other section of the article.

  3. Authors are prohibited from using AI as a source of scientific references cited in the manuscript or included in the reference list.

  4. All manuscript content, including data, analyses, interpretations of results, discussions, conclusions, tables, figures, and references, must be fully accountable to the authors and supported by valid scientific sources and research procedures.

  5. Authors bear full responsibility for the originality, accuracy, validity, and integrity of all content included in their submitted manuscripts.

  6. Manuscripts found to violate this policy may be rejected, have their editorial processing discontinued, or be subject to corrective measures in accordance with the journal's publication ethics policies.

2. Policy for Editors

  1. Editors are strictly prohibited from using generative AI technologies to perform any editorial duties, including initial manuscript assessment, evaluation of manuscript suitability, reviewer selection, assessment of peer review reports, editorial decision-making, and preparation of editorial communications.

  2. Editors are prohibited from uploading, entering, or sharing manuscripts, reviewer reports, research data, or any other confidential information with AI systems or services.

  3. Editors must maintain manuscript confidentiality, objectivity in evaluation, independence in editorial decision-making, and the security of information obtained throughout the publication process.

  4. All editorial decisions must be based on professional judgment, scientific considerations, and the journal's applicable policies.

3. Policy for Reviewers (Peer Reviewers)

  1. Reviewers are strictly prohibited from using generative AI technologies during the manuscript peer review process, including manuscript analysis, preparation of comments, formulation of recommendations, or preparation of peer review reports.

  2. Reviewers are prohibited from uploading or entering manuscripts, research data, figures, tables, or any other confidential information into AI systems or services.

  3. Reviewers must conduct their assessments independently, objectively, critically, and professionally, based on their scientific expertise and the principles of ethical scholarly publishing.

  4. Reviewers bear full responsibility for all comments, evaluations, and recommendations submitted to the Editors.

4. Policy for Copy Editors

  1. Copy Editors are strictly prohibited from using generative AI technologies to perform manuscript editing tasks, including language editing, grammar correction, sentence restructuring, verification of scientific terminology consistency, and adjustments to comply with the journal's editorial style and formatting guidelines.

  2. Copy Editors must carry out their editing responsibilities professionally while preserving the scientific meaning, accuracy of pharmaceutical terminology, and intended meaning conveyed by the authors.

  3. Copy Editors are prohibited from entering manuscripts or unpublished information into AI services.

  4. Copy Editors are responsible for the accuracy and quality of the edited manuscripts in accordance with the journal's publication standards.

5. Policy for Production Editors

  1. Production Editors are strictly prohibited from using generative AI technologies in any stage of article production, including layout preparation, formatting, arrangement of publication elements, final proofreading, and preparation of articles for publication.

  2. Production Editors must ensure that published articles conform to the approved manuscripts, completed editorial revisions, and the journal's technical publication standards.

  3. Production Editors are prohibited from uploading or entering manuscripts, production files, or any confidential unpublished information into AI systems or services.

  4. Production Editors are responsible for formatting accuracy, completeness of article elements, and the technical quality of the final published articles.

6. Policy Monitoring and Enforcement

The Indonesian Journal of Pharmaceutical Research reserves the right to investigate suspected violations of this AI usage policy based on relevant evidence and information. All suspected violations will be addressed proportionately, taking into account the nature and severity of the violation, the available evidence, and the principles of fairness throughout the editorial process.

Violations committed by Authors may result in manuscript rejection, termination of the publication process, or other corrective actions in accordance with the journal's policies. Violations committed by Editors, Reviewers, Copy Editors, or Production Editors may result in an evaluation of their assignments and administrative measures within the authority of the journal's management.

7. Final Provisions

All parties involved in the publication process of the Indonesian Journal of Pharmaceutical Research are required to read, understand, and comply with this policy. This policy is implemented to preserve the originality of scientific work, protect the confidentiality of information, and ensure the integrity and quality of scholarly publications.

The management of the Indonesian Journal of Pharmaceutical Research reserves the right to review and update this policy as necessary to reflect developments in AI technologies, scholarly publication ethics standards, and applicable regulations.

Indonesian Journal of Pharmaceutical Research (JRKI)

Scientific Integrity, Originality of Scholarly Work, and Accountability in Scholarly Publishing.